文献速递神经肿瘤

垂体腺瘤患者术后皮质醇减少症预测的术前列线图:单中心回顾性队列研究

A Preoperative Nomogram for Prediction of Postoperative Hypocortisolism in Patients with Pituitary Adenomas: A Single-Center Retrospective Cohort Study.
PubMed 文献 · World Neurosurg · 2023-08-14

该单中心回顾性队列纳入238例经蝶手术的垂体腺瘤患者,术后皮质醇减少症发生率为12.08%。研究识别出手术方式(内镜为保护因素,OR 0.24)、凝血酶原时间(OR 2.40)和嗜碱性粒细胞计数(OR 5.25)三个独立预测因子,并构建了预测列线图,其AUC为0.749,校准曲线良好。

要点

  • 术后皮质醇减少症发生率为12.08%。
  • 内镜手术较显微镜手术降低术后皮质醇减少症风险(OR 0.24,95%CI 0.093-0.610,P=0.003)。
  • 凝血酶原时间(OR 2.40)和嗜碱性粒细胞计数(OR 5.25)是独立预测因子。

核心结论

  • 手术方式、凝血酶原时间和嗜碱性粒细胞计数是术后皮质醇减少症最相关的预测因素。
  • 所构建的术前列线图可用于评估垂体腺瘤术后皮质醇减少症风险,有助于识别需要密切监测血清皮质醇水平及启动皮质醇给药治疗的高危患者。

研究设计与样本

  • 单中心回顾性队列研究,数据库包含2018年1月至2020年10月于金陵医院神经外科由不同医疗组经验丰富的神经外科医生收治并接受经蝶手术的438例连续垂体腺瘤患者,最终研究组纳入238例合格患者。
  • 收集年龄、性别、垂体腺瘤治疗史、术前体征和症状、原发复发亚型及临床亚型等可能预测因素的数据,采用单因素和多因素逻辑回归分析识别独立预测因子,并构建列线图模型,通过校准曲线和受试者工作特征曲线评估预测性能。

主要发现

  • 术后皮质醇减少症发生率为12.08%。
  • 手术方式(显微镜或内镜,内镜手术为保护因素)的OR为0.24(95%CI 0.093-0.610,P=0.003)。
  • 凝血酶原时间的OR为2.40(95%CI 1.332-4.326,P=0.004)。
  • 嗜碱性粒细胞计数的OR为5.25(95%CI 1.270-21.816,P=0.022)。
  • 列线图的受试者工作特征曲线下面积为0.749(95%CI 0.640-0.763),并生成了拟合良好的校准曲线,同时构建了交互式网络动态列线图应用。

临床怎么用

  • 作者认为该列线图有助于识别需要密切监测血清皮质醇水平的高危患者,并为需要皮质醇给药治疗作为挽救策略的患者启动临床流程。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with pituitary adenomas (PAs) are at an increased risk preoperatively and postoperatively for hypopituitarism. Postoperative hypocortisolism is associated with increased mortality and morbidity as well as poor quality of life. However, research about the risk factors for postoperative hypocortisolism is limited, and a predictive nomogram for postoperative hypocortisolism has not yet been developed. We aimed to investigate the predictive factors for postoperative hypocortisolism and construct a dynamic online nomogram. METHODS: Our database included 438 consecutive PA patients who were hospitalized and treated with transsphenoidal surgery by experienced neurosurgeons from the different medical teams in the Neurosurgery Department, Jinling Hospital, between January 2018 and October 2020. The final study group included 238 eligible patients. Data on possible predictors, including age, sex, treatment history of PAs, preoperative signs and symptoms, primary recurrence subtype, and clinical subtypes, were collected. Univariable and multivariable logistic regression analyses were applied to identify independent predictors, which were included in constructing the nomogram model. The calibration curve and receiver operating characteristic curve were computed to evaluate the predictive performance of the nomogram model. RESULTS: The incidence of postoperative hypocortisolism was 12.08%. Three preoperative predictors were identified to construct the nomogram: surgical type (microscopic or endoscopic, with endoscopic surgery proven to be the protective factor) (odds ratio, 0.24; 95% confidence interval [CI], 0.093-0.610; P = 0.003), prothrombin time (odds ratio, 2.40; 95% CI, 1.332-4.326; P = 0.004), and basophil cell count (odds ratio, 5.25; 95% CI, 1.270-21.816; P = 0.022,). The area under the curve of receiver operating characteristic curve for the constructed nomogram was 0.749 (95% CI, 0.640-0.763); a well-fixed calibration curve was generated for the nomogram model. An interactive web-based dynamic nomogram application was also constructed. CONCLUSIONS: In this study, surgical type, prothrombin time, and basophil cell count were the most relevant predictive factors for postoperative hypocortisolism. A predictive nomogram that can preoperatively assess the risk of hypocortisolism after surgical treatment of PAs was developed. This nomogram could be helpful in identifying high-risk patients who require close monitoring of serum cortisol levels and initiating clinical procedures for patients requiring cortisol administration therapy as a lifesaving strategy.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ali A, Cai X, Zhu J, et al. A Preoperative Nomogram for Prediction of Postoperative Hypocortisolism in Patients with Pituitary Adenomas: A Single-Center Retrospective Cohort Study. World Neurosurg. 2023. PMID: 37586551. doi:10.1016/j.wneu.2023.08.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。